We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.85%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.45B +$324M +1,448,990 +9%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$3.61B +$1.45B +6,495,508 +77%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.32B +$1.06B +4,721,721 +52%
State Street
4
State Street
Massachusetts
$2.58B +$462M +2,065,330 +24%
ClearBridge Investments
5
ClearBridge Investments
New York
$1.87B +$1.74B +7,754,197 New
BIT
6
BlackRock Institutional Trust
California
$1.61B +$495M +2,210,004 +50%
Franklin Resources
7
Franklin Resources
California
$1.2B +$391M +1,746,247 +54%
SC
8
Sculptor Capital
New York
$1.17B +$370M +1,652,109 +52%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$965M +$290M +1,297,402 +48%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$908M +$302M +1,351,107 +56%
Jennison Associates
11
Jennison Associates
New York
$823M +$444M +1,983,316 +139%
Northern Trust
12
Northern Trust
Illinois
$805M +$180M +806,405 +32%
BFA
13
BlackRock Fund Advisors
California
$702M +$166M +742,446 +34%
TP
14
Third Point
New York
$694M +$83.9M +375,000 +15%
BG
15
BlackRock Group
United Kingdom
$670M +$204M +910,584 +49%
O
16
OppenheimerFunds
New York
$650M -$93.2M -416,556 -13%
Viking Global Investors
17
Viking Global Investors
Connecticut
$615M +$300M +1,342,512 +111%
JHIU
18
Janus Henderson Investors US
Colorado
$607M +$100M +448,379 +22%
JP
19
Jana Partners
New York
$607M -$31.2M -139,627 -5%
LPC
20
Lone Pine Capital
Connecticut
$598M
Morgan Stanley
21
Morgan Stanley
New York
$529M +$51.3M +229,261 +12%
Massachusetts Financial Services
22
Massachusetts Financial Services
Massachusetts
$523M -$433K -1,937 -0.1%
AllianceBernstein
23
AllianceBernstein
Tennessee
$513M -$200M -895,863 -30%
TCIM
24
TIAA CREF Investment Management
New York
$508M +$88.9M +397,415 +23%
TIM
25
Thornburg Investment Management
New Mexico
$497M -$119M -533,479 -21%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.